Sharp D S, Enright P L, Chiu D, Burchfiel C M, Rodriguez B L, Curb J D
National Heart, Lung, and Blood Institute, Bethesda, Maryland, USA.
Am J Respir Crit Care Med. 1996 Feb;153(2):805-11. doi: 10.1164/ajrccm.153.2.8564136.
Pulmonary function was assessed by spirometry in 3,076 elderly Japanese-American men of the Honolulu Heart Program (HHP) cohort. The assessment was done with a stringent quality assurance program that adhered to American Thoracic Society (ATS) recommendations for spirometry. Less than 6% of the participants were unable to perform three acceptable spirometry maneuvers. A "healthy" subgroup of 528 men between the ages of 71 and 90 yr was identified by excluding almost all smokers and subjects with lung disease and other factors negatively influencing FEV1. Reference equations and normal ranges for FEV1, FVC, and the FEV1/FVC ratio were derived from the healthy group. Use of prediction equations from the Cardiovascular Health Study (CHS) of elderly European-American men consistently overpredicted FVC by 0.3 to 0.4 L and FEV1 by 0.15 L. Men in the HHP were on average 11 cm shorter than those in the CHS. Use of a prediction equation derived from the HHP cohort when the men in the cohort were on average 22.6 yr younger consistently overpredicted FEV1 by 0.2 to 0.3 L. These results underscore the importance of using prediction equations appropriate to the ethnicity, age, and height characteristics of the subjects being studied.
通过肺活量测定法对檀香山心脏项目(HHP)队列中的3076名日裔美国老年男性进行了肺功能评估。评估采用了严格的质量保证程序,该程序遵循了美国胸科学会(ATS)关于肺活量测定法的建议。不到6%的参与者无法完成三次可接受的肺活量测定动作。通过排除几乎所有吸烟者以及患有肺部疾病和其他对第一秒用力呼气量(FEV1)有负面影响因素的受试者,确定了一个由528名年龄在71岁至90岁之间的男性组成的“健康”亚组。从该健康组得出了FEV1、用力肺活量(FVC)以及FEV1/FVC比值的参考方程和正常范围。使用来自欧美老年男性心血管健康研究(CHS)的预测方程始终会使FVC预测值高估0.3至0.4升,FEV1预测值高估0.15升。HHP队列中的男性平均比CHS队列中的男性矮11厘米。当该队列中的男性平均年龄小22.6岁时,使用从HHP队列得出的预测方程始终会使FEV1预测值高估0.2至0.3升。这些结果强调了使用适合所研究对象的种族、年龄和身高特征的预测方程的重要性。